Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Capital Employed: 2011-2025

Historic Return on Capital Employed for Ironwood Pharmaceuticals (IRWD) over the last 14 years, with Sep 2025 value amounting to 0.97%.

  • Ironwood Pharmaceuticals' Return on Capital Employed rose 68.00% to 0.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.97%, marking a year-over-year increase of 68.00%. This contributed to the annual value of 0.25% for FY2024, which is 211.00% up from last year.
  • As of Q3 2025, Ironwood Pharmaceuticals' Return on Capital Employed stood at 0.97%, which was up 35.64% from 0.72% recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Return on Capital Employed's 5-year high stood at 0.97% during Q3 2025, with a 5-year trough of -4.91% in Q1 2024.
  • Its 3-year average for Return on Capital Employed is -1.00%, with a median of 0.23% in 2023.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Return on Capital Employed crashed by 514bps in 2024 and then spiked by 509bps in 2025.
  • Quarterly analysis of 5 years shows Ironwood Pharmaceuticals' Return on Capital Employed stood at 0.25% in 2021, then fell by 1bps to 0.24% in 2022, then tumbled by 451bps to -4.27% in 2023, then skyrocketed by 455bps to 0.28% in 2024, then soared by 68bps to 0.97% in 2025.
  • Its Return on Capital Employed stands at 0.97% for Q3 2025, versus 0.72% for Q2 2025 and 0.18% for Q1 2025.